Alto Neuroscience (ANRO) Total Liabilities (2023 - 2026)

Alto Neuroscience has disclosed Total Liabilities across 4 years of filings, most recently posting $32.9 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $32.9 million, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.9 million (changed 0.22% YoY), and the FY2025 annual result was $33.5 million, up 28.62% from the prior year.
• Total Liabilities came in at $32.9 million for Q1 2026 at Alto Neuroscience, down from $33.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $61.1 million in Q3 2023 to a low of $16.8 million in Q1 2024.
• The 4-year median for Total Liabilities is $32.9 million (2026), against an average of $33.2 million.
• Across the five-year window, Total Liabilities plunged 66.57% in 2024 and jumped 96.0% in 2025, its largest moves.
• Alto Neuroscience's Total Liabilities stood at $16.8 million in 2023, then surged by 55.04% to $26.1 million in 2024, then grew by 28.62% to $33.5 million in 2025, then slipped by 1.96% to $32.9 million in 2026.
• The last three Total Liabilities figures came in at $32.9 million (Q1 2026), $33.5 million (Q4 2025), and $35.4 million (Q3 2025), per Business Quant data.